Infliximab for Paradoxical Reactions in Pediatric Central Nervous System Tuberculosis
Journal of the Pediatric Infectious Diseases Society, Volume 10, No. 12, Year 2021
Notification
URL copied to clipboard!
Paradoxical reactions in central nervous system tuberculosis (CNS-TB) are associated with significant morbidity and mortality. We describe 4 HIV-uninfected children treated for CNS-TB with severe paradoxical reactions unresponsive to corticosteroids. All made recovery after treatment with infliximab, highlighting the safety and effectiveness of infliximab for this complication, and need for prospective trials.